Search

everythinglearnresearchcommunity

for

Search:↓

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

The document concludes that treating PCOS requires a combination of drugs to manage reproductive and metabolic symptoms, with more research needed on combination therapies.

Finasteride reduces male rat fertility by causing issues with copulatory plug formation.

Sweat glands and hair follicles are structurally connected within a specific layer of skin fat.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

A male with aromatase deficiency improved bone health with estradiol treatment.

Personalized treatment plans improve vitiligo care.

Prolactin may affect hair growth differently based on gender and scalp area.

Food deprivation increases MST enzyme in the brain, possibly affecting energy balance.

Most pregnant women experience skin changes like darkening and stretch marks, and some may have skin conditions that usually get better after giving birth.

Mice with enhanced regeneration abilities may help develop new regenerative medicine therapies.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Cell-based therapies using dermal papilla cells and adipocyte lineage cells show potential for hair regeneration.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Applying calreticulin can speed up wound healing in diabetics.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Minoxidil metabolizes similarly in monkeys and humans, but differently in dogs and rats.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Diagnosing PCOS in teenagers is hard because its symptoms often look like normal puberty, and there's a need for better diagnosis methods and agreement on criteria.